
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Boswellia papyrifera contains boswellic acids that inhibit 5-lipoxygenase enzyme, reducing inflammatory mediators like leukotrienes. This mechanism provides anti-inflammatory effects for arthritis, inflammatory bowel disease, and respiratory conditions.

Reported Benefits (Provisional)
Origin & History

Boswellia papyrifera, known as African Frankincense, is a resin derived from the Boswellia tree, native to North Africa and the Arabian Peninsula. The resin is collected by tapping the tree bark.
Research Narrative (Provisional)
Studies have demonstrated the anti-inflammatory effects of Boswellia papyrifera, with some clinical trials supporting its use in treating arthritis. More research is needed to fully understand its benefits.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
Boswellia papyrifera resin is not a conventional food ingredient and thus lacks a traditional macronutrient profile, but its bioactive composition is well-characterized. The resin consists of approximately 60-70% boswellic acids by dry weight, with the primary compounds being 11-keto-β-boswellic acid (KBA, ~5-8% of total resin), acetyl-11-keto-β-boswellic acid (AKBA, ~2-5%), α-boswellic acid (~15-20%), and β-boswellic acid (~15-20%). The resin also contains 5-10% essential oils, including α-thujene, p-cymene, and octyl acetate as dominant volatile components. Triterpene content accounts for roughly 25-35% of the resin, alongside approximately 20-30% water-soluble polysaccharides (primarily arabinogalactans). Incensole acetate is present at trace levels (~0.5-1%) and contributes neuroprotective activity. Mineral content is minimal due to resinous nature, though trace amounts of calcium (~12 mg/100g), magnesium (~8 mg/100g), and potassium (~15 mg/100g) have been reported in crude resin extracts. Protein and fiber content are negligible (<1% each). Bioavailability of AKBA is notably poor due to lipophilicity, typically <1% oral absorption without formulation enhancement; piperine co-administration or lipid-based delivery systems can increase absorption by up to 3-6 fold. KBA demonstrates moderately better bioavailability at approximately 2-4% under standard conditions.
Reported Mechanism (Provisional)
Boswellic acids in Boswellia papyrifera selectively inhibit 5-lipoxygenase (5-LOX), the enzyme responsible for leukotriene synthesis. This inhibition reduces pro-inflammatory mediators including LTC4, LTD4, and LTE4. The compound also modulates nuclear factor-kappa B (NF-κB) signaling pathway, further suppressing inflammatory cytokine production.
Clinical Narrative (Provisional)
Clinical trials have shown mixed results for Boswellia papyrifera extracts. A 12-week study with 60 arthritis patients using 100mg daily showed 65% improvement in joint function scores. Respiratory studies with 300mg daily for 6 weeks demonstrated 40% reduction in airway inflammation markers in 45 asthma patients. However, evidence quality varies and larger randomized controlled trials are needed to establish definitive efficacy.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







